Cargando…

Fingolimod induced fulminant liver failure requiring liver transplantation: A case report

Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Caliskan, Ali Riza, Muhip Harputluoglu, Muhsin Murat, Samdanci, Emine, Cirik, Salih, Yilmaz, Sezai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209975/
https://www.ncbi.nlm.nih.gov/pubmed/37250929
http://dx.doi.org/10.14744/hf.2022.2022.0033
_version_ 1785046978828173312
author Caliskan, Ali Riza
Muhip Harputluoglu, Muhsin Murat
Samdanci, Emine
Cirik, Salih
Yilmaz, Sezai
author_facet Caliskan, Ali Riza
Muhip Harputluoglu, Muhsin Murat
Samdanci, Emine
Cirik, Salih
Yilmaz, Sezai
author_sort Caliskan, Ali Riza
collection PubMed
description Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 – year – old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis.
format Online
Article
Text
id pubmed-10209975
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-102099752023-05-26 Fingolimod induced fulminant liver failure requiring liver transplantation: A case report Caliskan, Ali Riza Muhip Harputluoglu, Muhsin Murat Samdanci, Emine Cirik, Salih Yilmaz, Sezai Hepatol Forum Case Report Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 – year – old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis. Kare Publishing 2023-05-18 /pmc/articles/PMC10209975/ /pubmed/37250929 http://dx.doi.org/10.14744/hf.2022.2022.0033 Text en © Copyright 2023 by Hepatology Forum https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Case Report
Caliskan, Ali Riza
Muhip Harputluoglu, Muhsin Murat
Samdanci, Emine
Cirik, Salih
Yilmaz, Sezai
Fingolimod induced fulminant liver failure requiring liver transplantation: A case report
title Fingolimod induced fulminant liver failure requiring liver transplantation: A case report
title_full Fingolimod induced fulminant liver failure requiring liver transplantation: A case report
title_fullStr Fingolimod induced fulminant liver failure requiring liver transplantation: A case report
title_full_unstemmed Fingolimod induced fulminant liver failure requiring liver transplantation: A case report
title_short Fingolimod induced fulminant liver failure requiring liver transplantation: A case report
title_sort fingolimod induced fulminant liver failure requiring liver transplantation: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209975/
https://www.ncbi.nlm.nih.gov/pubmed/37250929
http://dx.doi.org/10.14744/hf.2022.2022.0033
work_keys_str_mv AT caliskanaliriza fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport
AT muhipharputluoglumuhsinmurat fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport
AT samdanciemine fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport
AT ciriksalih fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport
AT yilmazsezai fingolimodinducedfulminantliverfailurerequiringlivertransplantationacasereport